Advertisement

Showing posts with the label GranulesShow All
Granules India Announces Closing of Acquisition of Senn Chemicals, Strengthening Capabilities in Peptide Therapeutics and CDMO Services
Granules India’s ‘Breast Health Express’ Brings Life-Saving Screenings to Women Police Officers
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Granules’ Net Zero Commitment Validated and Approved by Science Based Targets Initiative
Mr.OvaisSarmad joins as Advisor to Granules India Limited to Guide Sustainability and Climate Strategy
Granules India Limited Honoured with Golden Peacock Award for Sustainability, Setting New Standards in Environmental Responsibility
Granules India’s Unit V Facility SecuresUS FDA EIR with 'No Action Indicated' Status
Load More That is All